Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Immuron Limited ( (AU:IMC) ) just unveiled an update.
Immuron Limited has issued 135,800 ordinary shares without disclosure under Part 6D.2 of the Corporations Act. The company has complied with the relevant provisions of the Corporations Act and confirms there is no excluded information required to be disclosed, indicating a transparent and compliant operational stance.
More about Immuron Limited
Immuron Limited operates in the biotechnology industry and is primarily focused on the development and commercialization of oral immunotherapeutic products for the treatment of gut-mediated diseases.
Average Trading Volume: 108,473
Technical Sentiment Signal: Sell
Current Market Cap: A$14.72M
Learn more about IMC stock on TipRanks’ Stock Analysis page.